Eli Lilly’s experimental oral drug, orforglipron, has demonstrated impressive results in clinical trials for weight loss and diabetes management. Among diabetic participants, the drug achieved an average weight loss of 7.9% (approximately 7.2 kg), surpassing the 6% observed with Novo Nordisk’s injectable Ozempic. Orforglipron also reduced blood sugar levels by 1.3%, slightly less than Ozempic, but its oral administration marks a significant innovation in treatment options. The drug,...

Heineken, one of the world’s leading brewers, reported a decline in revenue for the first quarter of 2025. The company’s performance was impacted by reduced beer sales in Europe, North America, and South America. Contributing factors included a later Easter holiday and one fewer trading day compared to the same period last year, as 2024 was a leap year. Despite these challenges, Heineken managed to ship over 54...

Ferrari, the legendary luxury car manufacturer, continues its commitment to innovation and sustainability. The company’s shareholder meeting recently highlighted a strong financial performance in 2024, including the approval of a dividend of €2.986 per ordinary share marking a 22% increase compared to the previous year. Ferrari is not only focused on solid financial results but also on advancing its industrial plan. The CEO, Benedetto Vigna, described 2024 as...

C3.ai, an enterprise AI software applications company, experienced a drop in its share price on Monday, declining by 2.57% to close at $20.06. This decrease followed an investment firm’s decision to revise its price target for the company downward. DA Davidson lowered the target from $25 to $18, citing broader economic challenges, including the possibility of negative GDP growth in upcoming quarters. As part of the reassessment, the...

Apple Inc. witnessed a notable rebound in its stock price following tariff exclusions on smartphones and electronics announced by the Trump administration. On Monday, Apple shares surged by as much as 7% to a high of $212.94, eventually settling up 4.5% at $206.05. The exemption from tariffs is seen as a crucial development for technology firms that rely on imports from China. The rise in Apple’s stock also...